Abu Dhabi Built a Path for AI to Perform Clinical Work. It Has Not Licensed an AI Doctor Yet

Abu Dhabi is preparing for a healthcare question that still sounds futuristic: what evidence would an artificial-intelligence system need before it could perform clinical work normally reserved for a licensed clinician?

The Department of Health has now published an AI Clinician Framework designed to answer that question.

It creates a regulatory structure for researching, evaluating and potentially authorising AI clinician systems.

It does not mean an autonomous AI doctor has already been licensed to practise in Abu Dhabi.

Authorisation would attach to specific clinical activities

Under the framework, competence is assessed against the clinical activities an AI system is intended to perform.

A system seeking a broader clinical scope would need stronger evidence and a higher demonstrated level of competence before it could be considered.

That makes the proposed regulatory model activity-based rather than treating an AI product as simply safe or unsafe for medicine as a whole.

The framework is not the final permission

The Department of Health says the framework will provide the basis for future policies and supporting standards.

Those later rules will define which clinical activities an AI clinician could be authorised to perform, what evidence is required at each stage and the thresholds used to evaluate it.

Publication of the framework therefore creates the pathway toward possible authorisation rather than granting that authorisation itself.

Physicians remain inside the system

The framework requires safeguards across levels of clinical scope, including physician oversight and accountability.

AI clinician systems must also be able to refer a case to a physician when necessary.

That means the current regulatory direction is not built around removing licensed clinicians from responsibility entirely.

More autonomy would require more evidence

An AI system performing a narrow clinical task creates a different risk from one expected to make decisions across a much wider range of patient situations.

Abu Dhabi's approach links the breadth of clinical activity to the strength of evidence required.

The more an AI system is expected to do, the more competence it must demonstrate before regulators consider expanding its scope.

Research comes before routine care

Research under the framework will take place through Abu Dhabi's living-lab model and governed clinical research pathways.

That creates a controlled environment in which systems can be studied before a wider operating permission is considered.

A successful research programme should therefore not automatically be read as permission for routine clinical deployment.

AI healthcare regulation is moving beyond software approval

The interesting part of the framework is that Abu Dhabi is preparing for systems that may eventually perform clinical activities rather than simply support a physician with information.

That raises harder questions around competence, escalation, accountability and the boundaries of machine decision-making.

Those questions become more important as AI moves from recommending an action toward performing parts of the clinical role itself.

What Arabian Current is watching

Watch the first supporting standards, the clinical activities selected for research, evidence thresholds, authorised scope and how physician intervention works as AI systems gain greater independence.

The real state change will come when a specific AI clinician system moves from research into a clearly defined authorised clinical activity.